Related Experiment Videos
[Hepatic coagulopathy--principles and therapeutic statements]
Leber, Magen, Darm
|October 1, 1982
Summary
Plasma levels of prothrombin complex and antithrombin III correlate with liver disease severity, aiding disease monitoring. Maintaining coagulation factor balance is crucial for managing hemostatic disorders in liver failure.
Area of Science:
- Hepatology
- Hematology
- Biochemistry
Context:
- Liver parenchymal diseases significantly impact coagulation factor levels.
- Hepatic dysfunction alters the clearance of activated coagulation factors.
- Coagulation factor imbalances predispose patients to hemostatic complications.
Purpose:
- To investigate the correlation between plasma coagulation factor concentrations and liver disease severity.
- To evaluate the utility of coagulation factors in monitoring liver disease progression.
- To explore therapeutic strategies for managing hemostatic disorders in liver failure.
Summary:
- Plasma concentrations of prothrombin complex factors and antithrombin III significantly correlate with the severity of liver parenchymal disease.
- These factors, with short biological half-lives, are valuable for monitoring disease course.
- Liver failure impairs hepatic clearance of activated factors, increasing risks like disseminated intravascular coagulation, especially during infections or shock.
Impact:
- Establishes key biomarkers for assessing liver disease severity and progression.
- Highlights the critical role of maintaining hemostatic balance in liver failure patients.
- Informs therapeutic approaches, emphasizing equilibrium between procoagulant and anticoagulant factors for optimal patient outcomes.